China Health Resource, Inc. Secures Warehouse Space for Increased Angelica Storage

Share Article

China Health Resource, Inc. obtains upscale modern warehouse to ensure adequate market supply for increased Angelica production storage.

Dahurian Angelica Root

The Company’s growth opportunities are tremendous, and we are pleased to expand our current facility to cater to the rising demand for DAR.

China Health Resource, Inc. (OTCBB: CHRI) is a leading Chinese pharmaceutical company specializing in producing, processing, and commercializing Dahurian Angelica Root (DAR). Today, CHRI announced that the company has secured a large warehouse in Chuanshan District, in Suining City, in order to meet the growing market demands for increased DAR production. Covering 625 square meters, the new warehouse will ensure adequate market supply for storing high-quality DAR, which CHRI is widely known for.

CHRI has become a solid leader in DAR production in Sichuan Province, enticing many pharmaceutical companies to establish long-term agreements with the company for their ample supply of DAR. As a result, CHRI has secured two consecutive Letters of Intent to increase the purchase quantity of DAR with reputable leading enterprises within the pharmaceutical industry; Sichuan Zhiyuan Aquarious Pharmacy Co., Ltd and Chengdu Longevity Church Business Co., Ltd.

“The Company’s growth opportunities are tremendous, and we are pleased to expand our current facility to cater to the rising demand for DAR,” stated Jiayin Wang, CEO, CHRI.

The modern, upscale warehouse, selected by CHRI, covers 625 square meters and is located in Chuanshan District in Suining City. With the additional 520 square meters the company currently uses for DAR storage, capacity will reach 2,800 tons, valuing at 50 million yuan.

Additional information about China Health Resource, Inc. can be found by visiting

About CHRI
China Health Resource, Inc. (CHRI) engages in the development, manufacturing, processing, marketing, and sale of Dahurian Angelica Root (DAR) and related products in the People's Republic of China. DAR, which is also known as “Bai Zhi” in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The company's DAR-related products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of which are sold through regional distributors. The company was founded in 2001 and is based in Suining.

Certain statements found other than historical facts in this document regarding financial matters other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words "believe", "expect", "anticipate", "optimistic", "intend", "will", and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Management retains broad discretion with regard to all future business operations of the Company. Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rebecca Binny-Hallmark
Visit website